Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark?When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!!Just BAN this Genetically-Engineered poison! [bAN RoundUp, too!]rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight!============http://www.bloomberg.com/apps/news?pid=20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoAug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows.The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops.Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free.``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.''Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration'' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said.Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41.10 Pounds a DayPosilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent.Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe.The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.''Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes.To contact the reporter on this story: Lopatto in New York at elopatto@... =====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 This is absolutely OKAY and not OT, Viviane and you are right, we need to be alert and watch them closely. The FDA approved this poison against the will and warnings of its own scientists thanks to Monsanto's who was quickly pushed through the FDA's legendary revolving door. Mind you, this is a veterinary drug and the FDA's remarks that the "risks to humans are MANAGEABLE" are downright criminal. Of course, it will be "manageable" and "benefit" the billion-dollar coffers of the cancer industry, since this drug has been linked to colon, prostrate and breast cancer. Roundup contains glyphosate, which has been linked to various types of cancer, including non-Hodgkins lymphoma. http://www.ghorganics.com/Glyphosate.htm Ingrid I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically-Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomberg.com/apps/news?pid=20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration'' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopatto@... ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 20, 2008 Report Share Posted August 20, 2008 This is absolutely OKAY and not OT, Viviane and you are right, we need to be alert and watch them closely. The FDA approved this poison against the will and warnings of its own scientists thanks to Monsanto's who was quickly pushed through the FDA's legendary revolving door. Mind you, this is a veterinary drug and the FDA's remarks that the "risks to humans are MANAGEABLE" are downright criminal. Of course, it will be "manageable" and "benefit" the billion-dollar coffers of the cancer industry, since this drug has been linked to colon, prostrate and breast cancer. Roundup contains glyphosate, which has been linked to various types of cancer, including non-Hodgkins lymphoma. http://www.ghorganics.com/Glyphosate.htm Ingrid I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically-Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomberg.com/apps/news?pid=20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration'' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopatto@... ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board....On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick@...> wrote: From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk " NO FORCED VACCINATION " <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Hi Monika and those who have written to me privately expressing their annoyance at Ted's unacceptable behavior. I did NOT forward his mail below to the list, which once again he had posted to non-members and other lists in violation of the rules of this forum. And since private mails sent to Ted were returned to me for some unfathomable reason, the last message reading as follows: " Ted, once again you have chosen to ignore the rules of this forum by forwarding posts from this list to non-members and other lists. This is my last warning! Ingrid Blank I hereby repeat my warning, namely that I will unsubscribe him immediately and ban him from this list, if he choses to deliberately ignore and violate the rules of this forum. The mail below expressing the thoughts and opinion of a list member, meant to be shared with members subscribed to this list ONLY and "copyrighted property" of this particular list member, is the perfect example of such violation. Ingrid Blank Moderator Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick@...> wrote: From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Hi Monika and those who have written to me privately expressing their annoyance at Ted's unacceptable behavior. I did NOT forward his mail below to the list, which once again he had posted to non-members and other lists in violation of the rules of this forum. And since private mails sent to Ted were returned to me for some unfathomable reason, the last message reading as follows: " Ted, once again you have chosen to ignore the rules of this forum by forwarding posts from this list to non-members and other lists. This is my last warning! Ingrid Blank I hereby repeat my warning, namely that I will unsubscribe him immediately and ban him from this list, if he choses to deliberately ignore and violate the rules of this forum. The mail below expressing the thoughts and opinion of a list member, meant to be shared with members subscribed to this list ONLY and "copyrighted property" of this particular list member, is the perfect example of such violation. Ingrid Blank Moderator Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick@...> wrote: From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Hi Monika and those who have written to me privately expressing their annoyance at Ted's unacceptable behavior. I did NOT forward his mail below to the list, which once again he had posted to non-members and other lists in violation of the rules of this forum. And since private mails sent to Ted were returned to me for some unfathomable reason, the last message reading as follows: " Ted, once again you have chosen to ignore the rules of this forum by forwarding posts from this list to non-members and other lists. This is my last warning! Ingrid Blank I hereby repeat my warning, namely that I will unsubscribe him immediately and ban him from this list, if he choses to deliberately ignore and violate the rules of this forum. The mail below expressing the thoughts and opinion of a list member, meant to be shared with members subscribed to this list ONLY and "copyrighted property" of this particular list member, is the perfect example of such violation. Ingrid Blank Moderator Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick@...> wrote: From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Hi Monika and those who have written to me privately expressing their annoyance at Ted's unacceptable behavior. I did NOT forward his mail below to the list, which once again he had posted to non-members and other lists in violation of the rules of this forum. And since private mails sent to Ted were returned to me for some unfathomable reason, the last message reading as follows: " Ted, once again you have chosen to ignore the rules of this forum by forwarding posts from this list to non-members and other lists. This is my last warning! Ingrid Blank I hereby repeat my warning, namely that I will unsubscribe him immediately and ban him from this list, if he choses to deliberately ignore and violate the rules of this forum. The mail below expressing the thoughts and opinion of a list member, meant to be shared with members subscribed to this list ONLY and "copyrighted property" of this particular list member, is the perfect example of such violation. Ingrid Blank Moderator Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick@...> wrote: From: Viviane Lerner <vivlerner@...>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Look, Ted, here's the rule of that game:You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author.For instance, here you could send out to the whole world everything that starts with the URL:http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoOn Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc.But NOT my personal comments [at the beginning] without my per;ission.OK?Viviane===========Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board....On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote:--- On Wed, 8/20/08, Viviane Lerner <vivlernergmail> wrote:From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PMI hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark?When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!!Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!]rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight!============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoAug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows.The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops.Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free.``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.''Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said.Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41.10 Pounds a DayPosilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent.Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe.The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.''Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes.To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net=====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Look, Ted, here's the rule of that game:You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author.For instance, here you could send out to the whole world everything that starts with the URL:http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoOn Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc.But NOT my personal comments [at the beginning] without my per;ission.OK?Viviane===========Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board....On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote:--- On Wed, 8/20/08, Viviane Lerner <vivlernergmail> wrote:From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PMI hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark?When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!!Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!]rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight!============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoAug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows.The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops.Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free.``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.''Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said.Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41.10 Pounds a DayPosilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent.Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe.The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.''Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes.To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net=====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Look, Ted, here's the rule of that game:You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author.For instance, here you could send out to the whole world everything that starts with the URL:http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoOn Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc.But NOT my personal comments [at the beginning] without my per;ission.OK?Viviane===========Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board....On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote:--- On Wed, 8/20/08, Viviane Lerner <vivlernergmail> wrote:From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PMI hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark?When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!!Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!]rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight!============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoAug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows.The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops.Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free.``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.''Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said.Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41.10 Pounds a DayPosilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent.Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe.The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.''Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes.To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net=====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 22, 2008 Report Share Posted August 22, 2008 Look, Ted, here's the rule of that game:You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author.For instance, here you could send out to the whole world everything that starts with the URL:http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoOn Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc.But NOT my personal comments [at the beginning] without my per;ission.OK?Viviane===========Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board....On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote:--- On Wed, 8/20/08, Viviane Lerner <vivlernergmail> wrote:From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PMI hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark?When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!!Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!]rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight!============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=usLilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By LopattoAug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows.The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops.Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free.``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.''Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said.Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41.10 Pounds a DayPosilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent.Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe.The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.''Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes.To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net=====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 23, 2008 Report Share Posted August 23, 2008 Precisely Vivian, and this is the reason (conveyed to Ted in private mails) why I withheld his post and did not forward it to the list in the first place. However, given the fact that I live in a different time zone, someone must have thought that I had overlooked Ted's "immensely important" mail and promptly posted it to the list. One expects such behavior from a Kindergarten kid but not from an adult who (hopefully) should have developed his cognitive skills over the years. Moreover, he keeps sending personal comments from list members (INCLUDING their email addresses) to God and the world, thus making those list members easy targets for unsolicited spam and personal attacks from the many whackos out there. If he is not capable and willing to abide by the rules, he will be banned. Ingrid Look, Ted, here's the rule of that game: You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author. For instance, here you could send out to the whole world everything that starts with the URL: http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto On Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc. But NOT my personal comments [at the beginning] without my per;ission. OK? Viviane =========== Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote: From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 23, 2008 Report Share Posted August 23, 2008 Precisely Vivian, and this is the reason (conveyed to Ted in private mails) why I withheld his post and did not forward it to the list in the first place. However, given the fact that I live in a different time zone, someone must have thought that I had overlooked Ted's "immensely important" mail and promptly posted it to the list. One expects such behavior from a Kindergarten kid but not from an adult who (hopefully) should have developed his cognitive skills over the years. Moreover, he keeps sending personal comments from list members (INCLUDING their email addresses) to God and the world, thus making those list members easy targets for unsolicited spam and personal attacks from the many whackos out there. If he is not capable and willing to abide by the rules, he will be banned. Ingrid Look, Ted, here's the rule of that game: You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author. For instance, here you could send out to the whole world everything that starts with the URL: http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto On Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc. But NOT my personal comments [at the beginning] without my per;ission. OK? Viviane =========== Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote: From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 23, 2008 Report Share Posted August 23, 2008 Precisely Vivian, and this is the reason (conveyed to Ted in private mails) why I withheld his post and did not forward it to the list in the first place. However, given the fact that I live in a different time zone, someone must have thought that I had overlooked Ted's "immensely important" mail and promptly posted it to the list. One expects such behavior from a Kindergarten kid but not from an adult who (hopefully) should have developed his cognitive skills over the years. Moreover, he keeps sending personal comments from list members (INCLUDING their email addresses) to God and the world, thus making those list members easy targets for unsolicited spam and personal attacks from the many whackos out there. If he is not capable and willing to abide by the rules, he will be banned. Ingrid Look, Ted, here's the rule of that game: You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author. For instance, here you could send out to the whole world everything that starts with the URL: http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto On Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc. But NOT my personal comments [at the beginning] without my per;ission. OK? Viviane =========== Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote: From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 23, 2008 Report Share Posted August 23, 2008 Precisely Vivian, and this is the reason (conveyed to Ted in private mails) why I withheld his post and did not forward it to the list in the first place. However, given the fact that I live in a different time zone, someone must have thought that I had overlooked Ted's "immensely important" mail and promptly posted it to the list. One expects such behavior from a Kindergarten kid but not from an adult who (hopefully) should have developed his cognitive skills over the years. Moreover, he keeps sending personal comments from list members (INCLUDING their email addresses) to God and the world, thus making those list members easy targets for unsolicited spam and personal attacks from the many whackos out there. If he is not capable and willing to abide by the rules, he will be banned. Ingrid Look, Ted, here's the rule of that game: You certainly can send out the articles themselves [that can be found on the Internet anyhow] but NOT the personal comments on anything. Those are special to this group, not meant for the outside. If you really feel that the comments add something to the article they refer to and would like to send them as well, then you MUST ask permission from the author. For instance, here you could send out to the whole world everything that starts with the URL: http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto On Aug 22, 2008, at 4:28 PM, Monika Reign B. wrote:etc.etc. But NOT my personal comments [at the beginning] without my per;ission. OK? Viviane =========== Ummmm this Ted guy is doing it again... I know he's trying to share information but he's breaking the rules of the board.... On Wed, Aug 20, 2008 at 11:51 PM, Ted Malnick <tlmalnick > wrote: From: Viviane Lerner <vivlernergmail>Subject: Lilly to Buy Monsanto's rBGH [Posilac]-Milk"NO FORCED VACCINATION" <no-forced-vaccination >Date: Wednesday, August 20, 2008, 11:40 PM I hope it isn't too OT, will you let me know, Ingrid, if you feel I'm too far off the mark? When you have stuff so toxic that even Starbucks doesn't want it, just give it to Big Pharma !!! Just BAN this Genetically- Engineered poison! [bAN RoundUp, too!] rBST/sBGH is bad for the cows, bad for us, what is this Pharma fiend going to use it for, now? New psychiatric drugs? Drugs for women who have trouble breast-feeding? They sure need to be watched! May they go bankrupt overnight! ============http://www.bloomber g.com/apps/ news?pid= 20601103 & sid=aOBViPDaXYmg & refer=us Lilly to Buy Monsanto's Cow-Milk Stimulating Hormone (Update3) By Lopatto Aug. 20 (Bloomberg) -- Eli Lilly & Co. agreed to pay at least $300 million for Monsanto Co.'s Posilac, a synthetic hormone used to boost milk production in cows. The agreement, announced today by both companies, will expand Lilly's veterinary operations and enable Monsanto, a maker of pesticides and seeds, to focus on genetically modified crops. Posilac has been on the market since 1994. Lilly, the maker of the antipsychotic drug Zyprexa, gains the U.S. sales force for Posilac and the manufacturing plant in Augusta, Georgia. It also inherits opposition to the hormone from consumer advocates who question its safety and from dairy processors, such as Dean Foods Co., which has labeled its milk as hormone-free. ``You'd assume the controversy is part of the price, so there must be some other reason Lilly wants this asset,'' said , an analyst for Lehman Brothers in New York, in a telephone interview today. ``Maybe it'll help them sell other products to those farmers. Animal health as a component for all pharma companies is a business they want to grow.'' Monsanto, of St. Louis, the world's biggest seed producer, said earlier this month it planned to sell the dairy hormone business. It doesn't disclose sales or profits from Posilac. Lilly, based in Indianapolis, said Monsanto will receive ``contingent consideration' ' in addition to the $300 million. The purchase is expected to be completed this year and won't change the forecast for 2008 earnings, Lilly said. Monsanto rose $5.22, or 4.6 percent, to $118.08 at 4:05 p.m. in New York Stock Exchange composite trading. Lilly fell 39 cents to $47.41. 10 Pounds a Day Posilac, known chemically as recombinant bovine somatotropin or rBST, is used on about one-third of U.S. dairy herds, according to Monsanto. It boosts the average cow's milk production by about 10 pounds a day, or about 15 percent. Though Posilac is not sold in Canada or parts of the European Union, the Food and Agriculture Organization of the United Nations said in 1998 that the hormone is safe. The Center for Food Safety, an advocacy group, says the drug causes increases in the risks of lameness, udder infections, and infertility in cows and may pose health risks to humans. The group has said it wants the Food and Drug Administration to remove the drug from the market ``through all available legal means.'' Monsanto Chief Executive Officer Hugh Grant is selling smaller, animal-agriculture units amid surging sales of crop products such as Roundup herbicide and engineered corn and soybean seeds. Monsanto in September sold its Choice Genetics unit, which mapped swine genes. To contact the reporter on this story: Lopatto in New York at elopattobloomberg (DOT) net ===== In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. __________ Information from ESET NOD32 Antivirus, version of virus signature database 3267 (20080714) __________The message was checked by ESET NOD32 Antivirus.http://www.eset.com Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.